Sir,
In their elegant study, Ü ç eyler et al. (2013) provide objective evidence of small fibre neuropathy in patients with fibromyalgia. They conclude that fibromyalgia may be a neuropathic pain syndrome (Ü ç eyler et al., 2013) . Small fibre neuropathy is a disorder of the peripheral nerves resulting in sensory changes and sympathetic dysfunction.
For years, we have proposed that fibromyalgia is a neuropathic pain syndrome based on the following three arguments: (i) fibromyalgia is a stimulus-independent pain state. There is no structural damage that could explain the pain intensity; (ii) the presence of allodynia as an essential feature of fibromyalgia; and (iii) the presence of paraesthesias as a distinctive feature of fibromyalgia (Martinez-Lavin et al., 2003) . It seems difficult to ascribe an aetiology other than neuropathic pain to a syndrome with such characteristics.
Among neuropathic pain syndromes, we proposed that fibromyalgia pain is sympathetically maintained based on the following issues: (i) the high frequency of physical or psychological trauma as a triggering event; (ii) diverse heart rate variability studies showing that patients with fibromyalgia have changes consistent with ongoing sympathetic hyperactivity (Lerma et al., 2011) ; and (iii) a double-blind study showing that norepinephrine injections rekindle fibromyalgia pain (Martinez-Lavin et al., 2002) .
Based on animal models of sympathetic pain, we focused our attention on dorsal root ganglia as potential sympathetic-nociceptive short-circuit sites in cases of fibromyalgia. Dorsal root ganglia contain the sensory fibres cell bodies. Trauma and/or infection trigger sympathetic sprouting within dorsal root ganglia through nerve growth factor over-expression. Such aberrant neuroplasticity enables catecholamines and sympathetic traffic to induce sensory neuron firing. Sodium channels play a pivotal role in this hyperexcitability. A sodium channel isoform (Na V1.7 ) encoded in gene SCN9A of chromosome 2q24.3 is predominantly expressed in the dorsal root ganglia pain-sensing neurons and sympathetic ganglia neurons and their fine-diameter axons.
In a pilot study, we described a particular SCN9A sodium channel gene variant (rs6754031 GG genotype) associated with severe fibromyalgia (Vargas-Alarcon et al., 2012) . On the other hand, Faber et al. (2012) reported that a gain of function mutations in sodium channel Na V1.7 , which render dorsal root ganglion neurons hyperexcitable, are present in a substantial proportion (28.6%; 8 of 28) of patients meeting strict criteria for small fibre neuropathy (Faber et al., 2012) . This preliminary information raises the possibility that some cases of fibromyalgia and small fibre neuropathy may have underlying dorsal root ganglia sodium channelopathy.
The Ü ç eyler et al. (2013) study reinforces our proposal of fibromyalgia as sympathetically maintained neuropathic pain syndrome. Sympathetic dysfunction provides a coherent explanation for the multiple non-pain related fibromyalgia symptoms (Martinez-Lavin, 2012) .
